MCT is currently involved in 5 COVID-19 clinical trials across Africa in 10 countries, (Tunisia, Rwanda, Ghana, Uganda, Kenya, Mozambique, Zimbabwe, Mali, Nigeria, Malawi) and close to 30 sites, aiming at more than 20,000 patients to be vaccinated. A big thanks to all the PIs and site staff who contribute by their hard work and …
MCT has been working on a challenging and exciting Lassa Fever study in Ghana. We’re taking a moment here to congratulate Prof. Koram and his team from the Noguchi MIMR site in Ghana, for their excellent work. 136 patients randomized so far. Keep this amazing pace!
MCT is proud to be successfully running a Polio Vaccine study with 1,119 patients randomized within 5 months and targeting around 3,000 patients by March 2022.
MCT would like to congratulate Dr Jahanjir Hossain and his team for completing the first cohort of the study.
20200904 MCT Insights_Plan to make HCV disappear in Egypt
